Literature DB >> 19184414

Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study.

Heather Greenlee1, Marilyn L Kwan, Isaac Joshua Ergas, Karen J Sherman, Sarah E Krathwohl, Christine Bonnell, Marion M Lee, Lawrence H Kushi.   

Abstract

Many women use complementary and alternative medicine (CAM) to maintain or improve their health. We describe CAM use among the first 1,000 participants enrolled in the Pathways Study, an ongoing prospective cohort study of women diagnosed with breast cancer (BC). Participants, identified by rapid case ascertainment in Kaiser Permanente Northern California, are women > or = 21 years diagnosed with first invasive BC. Comprehensive baseline data are collected on CAM use through in-person interviews. Study participants include 70.9% non-Hispanic whites, 10.2% Hispanics, 9.0% Asians, 6.5% African-Americans, and 3.4% others. Most women (82.2%) were diagnosed with AJCC stage I/II BC at average (+/-SD) age 59.5 (+/-12.0) years and reported prior use of at least one form of CAM (96.5% of participants). In the 5 years before diagnosis, CAM therapies used at least weekly by >20% of women included green tea, glucosamine, omega-3 fatty acids, prayer and religion. CAM use was high (86.1% of participants) in the period immediately following diagnosis; 47.5% used botanical supplements, 47.2% used other natural products, 28.8% used special diets, 64.2% used mind-body healing, and 26.5% used body/energy/other treatments. In multivariable analyses, frequent use of each CAM modality before and after diagnosis was associated with use of other CAM modalities and other health behaviors (i.e., high fruit/vegetable intake, lower BMI). CAM use before and after BC diagnosis is common in this diverse group of women. Our results emphasize the need for clinicians to discuss CAM use with all BC patients.

Entities:  

Mesh:

Year:  2009        PMID: 19184414      PMCID: PMC2991094          DOI: 10.1007/s10549-009-0315-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Complementary and alternative medicine use among adults: United States, 2002.

Authors:  Patricia M Barnes; Eve Powell-Griner; Kim McFann; Richard L Nahin
Journal:  Adv Data       Date:  2004-05-27

Review 2.  Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Authors:  Brian D Lawenda; Kara M Kelly; Elena J Ladas; Stephen M Sagar; Andrew Vickers; Jeffrey B Blumberg
Journal:  J Natl Cancer Inst       Date:  2008-05-27       Impact factor: 13.506

3.  Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants.

Authors:  Yali A Bair; Ellen B Gold; Gail A Greendale; Barbara Sternfeld; Shelley R Adler; Rahman Azari; Martha Harkey
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

4.  Alternative therapies used by women with breast cancer in four ethnic populations.

Authors:  M M Lee; S S Lin; M R Wrensch; S R Adler; D Eisenberg
Journal:  J Natl Cancer Inst       Date:  2000-01-05       Impact factor: 13.506

5.  Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study.

Authors:  Catherine Buettner; Candyce H Kroenke; Russell S Phillips; Roger B Davis; David M Eisenberg; Michelle D Holmes
Journal:  Breast Cancer Res Treat       Date:  2006-07-05       Impact factor: 4.872

Review 6.  Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Authors:  Mark Messina; Worta McCaskill-Stevens; Johanna W Lampe
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

7.  The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer.

Authors:  Marilie D Gammon; Alfred I Neugut; Regina M Santella; Susan L Teitelbaum; Julie A Britton; Mary Beth Terry; Sybil M Eng; Mary S Wolff; Steven D Stellman; Geoffrey C Kabat; Bruce Levin; H Leon Bradlow; Maureen Hatch; Jan Beyea; David Camann; Martin Trent; Ruby T Senie; Gail C Garbowski; Carla Maffeo; Pat Montalvan; Gertrud S Berkowitz; Margaret Kemeny; Marc Citron; Freya Schnabe; Allan Schuss; Steven Hajdu; Vincent Vincguerra; Gwen W Collman; G Iris Obrams
Journal:  Breast Cancer Res Treat       Date:  2002-06       Impact factor: 4.872

8.  The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California.

Authors:  Marilyn L Kwan; Christine B Ambrosone; Marion M Lee; Janice Barlow; Sarah E Krathwohl; Isaac Joshua Ergas; Christine H Ashley; Julie R Bittner; Jeanne Darbinian; Keren Stronach; Bette J Caan; Warren Davis; Susan E Kutner; Charles P Quesenberry; Carol P Somkin; Barbara Sternfeld; John K Wiencke; Shichun Zheng; Lawrence H Kushi
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

Review 9.  Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.

Authors:  Valerie S Eschiti
Journal:  Integr Cancer Ther       Date:  2007-12       Impact factor: 3.279

10.  A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.

Authors:  John P Pierce; Susan Faerber; Fred A Wright; Cheryl L Rock; Vicky Newman; Shirley W Flatt; Sheila Kealey; Vicky E Jones; Bette J Caan; Ellen B Gold; Mary Haan; Kathryn A Hollenbach; Lovell Jones; James R Marshall; Cheryl Ritenbaugh; Marcia L Stefanick; Cynthia Thomson; Linda Wasserman; Loki Natarajan; Ronald G Thomas; Elizabeth A Gilpin
Journal:  Control Clin Trials       Date:  2002-12
View more
  49 in total

1.  Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort.

Authors:  Heather Greenlee; Marilyn L Kwan; Lawrence H Kushi; Jun Song; Adrienne Castillo; Erin Weltzien; Charles P Quesenberry; Bette J Caan
Journal:  Cancer       Date:  2011-09-27       Impact factor: 6.860

2.  Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer.

Authors:  Suzanne C Danhauer; Leah P Griffin; Nancy E Avis; Stephanie J Sohl; Michelle T Jesse; Elizabeth L Addington; Julia A Lawrence; Michael J Messino; Jeffrey K Giguere; Shantae L Lucas; Susan K Wiliford; Edward Shaw
Journal:  J Community Support Oncol       Date:  2015-04

3.  Predictors of yoga use among patients with breast cancer.

Authors:  Krupali Desai; Marjorie A Bowman; Mary Lou Galantino; Chanita Hughes-Halbert; Neha Vapiwala; Angela Demichele; Jun J Mao
Journal:  Explore (NY)       Date:  2010 Nov-Dec       Impact factor: 1.775

4.  Prevalence and frequency of self-management strategies among female cancer survivors: the neglected roles of social relations and conscious living.

Authors:  Monika Sieverding; Nadine Ungar; Alexandra Fleischmann; Miruh Lee; Haitong Zhang; Margaux Mohnke; Nicole K Specht; Gerdi Weidner
Journal:  Support Care Cancer       Date:  2019-05-18       Impact factor: 3.603

5.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

6.  Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.

Authors:  Heather Greenlee; Alfred I Neugut; Laura Falci; Grace Clarke Hillyer; Donna Buono; Jeanne S Mandelblatt; Janise M Roh; Isaac J Ergas; Marilyn L Kwan; Marion Lee; Wei Yann Tsai; Zaixing Shi; Lois Lamerato; Lawrence H Kushi; Dawn L Hershman
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

7.  Complementary and alternative medicine use among US cancer survivors.

Authors:  Gabriella M John; Dawn L Hershman; Laura Falci; Zaixing Shi; Wei-Yann Tsai; Heather Greenlee
Journal:  J Cancer Surviv       Date:  2016-02-26       Impact factor: 4.442

8.  Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Authors:  Leanna J Standish; Erin Sweet; Eleonora Naydis; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2012-06-27       Impact factor: 3.279

Review 9.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

10.  Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.

Authors:  Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay
Journal:  J Womens Health (Larchmt)       Date:  2012-10-17       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.